Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bertz

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|November 18, 2000
Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioningH Veelken, R Wäsch, D Behringer, et al.
Epidemiology and Infection|March 8, 2012
Initially fewer bloodstream infections for allogeneic vs. autologous stem-cell transplants in neutropenic patientsS Hieke, H Bertz, M Dettenkofer, et al.
Statistics in Medicine|September 2, 2008
Statistical epidemic modeling with hospital outbreak dataM Wolkewitz, M Dettenkofer, H Bertz, et al.
Bone Marrow Transplantation|September 14, 2004
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectivesR Zeiser, H Bertz, A Spyridonidis, et al.
Bone Marrow Transplantation|November 2, 2004
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcomeR Zeiser, B Deschler, H Bertz, et al.
Bone Marrow Transplantation|January 12, 2010
Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantationU Denz, H Bertz, G Ihorst, et al.
Leukemia|June 2, 2007
Donor-derived mucosal epithelial cells after human hematopoietic cell transplantation are not derived from the CD34-positive fraction of the graftY Metaxas, A Spyridonidis, H Bertz, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Use of <sup>15</sup> N NMR Spectroscopy To Resolve the "Higher Order Cyanocuprate" Controversy: <sup>15</sup> N, <sup>6</sup> Li, and <sup>13</sup> C NMR Spectroscopic Investigations of CuCN-Derived Butyl CupratesSteven H Bertz, Karolina Nilsson, Öjvind Davidsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselectionM Engelhardt, H Bertz, M Afting, et al.
Transplantation Proceedings|December 27, 2012
Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantationM Waterhouse, J Duque-Afonso, R Wäsch, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|November 18, 2000
Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioningH Veelken, R Wäsch, D Behringer, et al.
Epidemiology and Infection|March 8, 2012
Initially fewer bloodstream infections for allogeneic vs. autologous stem-cell transplants in neutropenic patientsS Hieke, H Bertz, M Dettenkofer, et al.
Statistics in Medicine|September 2, 2008
Statistical epidemic modeling with hospital outbreak dataM Wolkewitz, M Dettenkofer, H Bertz, et al.
Bone Marrow Transplantation|September 14, 2004
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectivesR Zeiser, H Bertz, A Spyridonidis, et al.
Bone Marrow Transplantation|November 2, 2004
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcomeR Zeiser, B Deschler, H Bertz, et al.
Bone Marrow Transplantation|January 12, 2010
Improved outcome in relapsed and refractory myeloid malignancies for unrelated vs related donor allogeneic peripheral blood-derived hematopoietic cell transplantationU Denz, H Bertz, G Ihorst, et al.
Leukemia|June 2, 2007
Donor-derived mucosal epithelial cells after human hematopoietic cell transplantation are not derived from the CD34-positive fraction of the graftY Metaxas, A Spyridonidis, H Bertz, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Use of <sup>15</sup> N NMR Spectroscopy To Resolve the "Higher Order Cyanocuprate" Controversy: <sup>15</sup> N, <sup>6</sup> Li, and <sup>13</sup> C NMR Spectroscopic Investigations of CuCN-Derived Butyl CupratesSteven H Bertz, Karolina Nilsson, Öjvind Davidsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselectionM Engelhardt, H Bertz, M Afting, et al.
Transplantation Proceedings|December 27, 2012
Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantationM Waterhouse, J Duque-Afonso, R Wäsch, et al.
Pageof 12